Dose‐dependent elevation in amylase and lipase in response to teduglutide administration

Teduglutide has been used for patients with short bowel syndrome. Teduglutide can be a dose‐dependent triggering factor to increased amylase and lipase. Serum amylase and lipase levels should be monitored routinely for patients on teduglutide, and they should be screened before the initiation of tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Joshua, Kim, Myoung, Kim, Dong Wook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6509918/
https://www.ncbi.nlm.nih.gov/pubmed/31110724
http://dx.doi.org/10.1002/ccr3.2127